Lynparza
Generic name: Olaparib
Dosage form: tablets (150mg, 100mg)
Drug class:
PARP inhibitors
Usage of Lynparza
Lynparza is a targeted cancer medicine used to treat specific types of ovarian cancer, breast cancer, fallopian tube cancer, pancreatic cancer, prostate cancer, and peritoneal cancer. Lynparza is often used if your cancer has a specific genetic marker, including BRAC1, BRCA2, HRR, and HER2-negative. Your doctor will test you for this gene.
Lynparza (olaparib) is a tablet that is usually taken twice daily, with or without food.
Lynparza was first FDA-approved in 2014 for advanced ovarian cancer.
Lynparza side effects
Get emergency medical help if you have signs of an allergic reaction to Lynparza: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:
Your cancer treatments may be delayed if you have certain side effects.
Some people who take this medicine with a gonadotropin-releasing hormone (GnRH) medicine may develop a blood clot in the leg or in the lung. Call your doctor if you have pain or swelling in your arm or leg, shortness of breath, chest pain, rapid breathing, or fast heartbeats.
Common Lynparza side effects may include:
This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Lynparza
You should not use Lynparza if you are allergic to olaparib.
To make sure Lynparza is safe for you, tell your doctor if you have ever had:
Pregnancy
Lynparza can harm an unborn baby or cause a miscarriage if the mother or the father is using this medicine.
Breastfeeding
Do not breastfeed while using this medicine, and for at least 1 month after your last dose.
Relate drugs
How to use Lynparza
The dose is usually 300 mg orally 2 times a day. The dose may be changed by your doctor due to renal impairment or other factors.
Lynparza is available in 150 mg and 100mg tablets.
For more detailed dosing information, click on the link below.
Warnings
Lynparza affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, weakness, tiredness, trouble breathing, easy bruising or bleeding, blood in your urine or stools, or weight loss.
You will need weekly or monthly blood tests, and your cancer treatments may be delayed based on the results.
Some people who take olaparib with a gonadotropin-releasing hormone (GnRH) medicine may develop a blood clot in the leg or in the lung. Call your doctor if you have pain or swelling in your arm or leg, shortness of breath, chest pain, rapid breathing, or fast heartbeats.
Lynparza may also cause serious lung problems. Call your doctor if you have chest pain, wheezing, trouble breathing, or a new or worsening cough.
What other drugs will affect Lynparza
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Strong and Moderate CYP3A Inhibitors. Avoid using strong or moderate CYP3A inhibitors with this medicine. If a strong or moderate inhibitor must be used, then reduce the dose of Lynparza
Strong and Moderate CYP3A Inducers. Avoid using strong or moderate CYP3A inducers with this medicine as it decreases the olaparib exposure, which may reduce Lynparza effectiveness.
Other drugs may interact with Lynparza, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions